CenExel CIT

CIT a CenExel Center of Excellence, is thrilled to be an official part of the CenExel clinical research network alongside JBR, CBH, ACMR, RCA, ACT, and RCA. CIT joined the CenExel clinical site network in early 2021, and now enjoys working with an expanded team with additional resources. CenExel strengthens CIT to reach new heights in clinical research, which is why the CenExel logo represents a mountain peak. We achieve this by offering unparalleled patient engagement, staff expertise, and valuable results. Sponsor and patient safety and efficacy is our top priority, and we look forward to continuing a partnership with our valued sponsors and CRO's as we explore the work we will do together. CenExel CIT specializes in the advancement of treatment for illnesses in the central nervous system (CNS) and in other therapeutic areas. We are dedicated to providing cutting-edge therapy that can assist pharmaceutical companies and patients in finding new treatments for a variety of CNS diseases and beyond. We conduct medical research from phase I first-in-human trials through phase IV trials of both medical and behavioral treatments. We provide full-service medical research, from top-ranked participant recruitment, medical record keeping, and everything in between on our two Center locations. We are and will continue to be dedicated to the clinical research of illnesses that affect the lives of millions of people every day. Over the past 20 years, we have assisted in the advancement of critical scientific milestones, helping bring important and safe CNS medications to the world. Click our bio link to learn how we can help you with your clinical trial needs.